Home

Glenmark Pharmaceuticals Ltd 52 Week Low

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

YEARLOW

₹ 958

Last updated on: Apr 01, 2025

Key Highlights

  • The 52 Week Low of Glenmark Pharmaceuticals Ltd is ₹ 958 as of 01 Apr 25 .

Company Fundamentals for Glenmark Pharmaceuticals Ltd

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
01 Apr 20251508.75
28 Mar 20251540.05
27 Mar 20251520.75
26 Mar 20251464.1
25 Mar 20251480.2
24 Mar 20251493.1
21 Mar 20251511.45
20 Mar 20251478.15
19 Mar 20251486.55
18 Mar 20251457.85

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Glenmark Pharmaceuticals Ltd News Hub

Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session

Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1

Read more

21 Aug 24

Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163

Read more

19 Aug 24

Glenmark Pharma gains after American subsidiary launches Olopatadine generic

The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L

Read more

19 Aug 24

Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio

Read more

19 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Glenmark Pharmaceuticals Ltd

Why is it important to track the 52-week low of Glenmark Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glenmark Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Glenmark Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Glenmark Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Glenmark Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Glenmark Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Glenmark Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Glenmark Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Glenmark Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Glenmark Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Glenmark Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Glenmark Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Glenmark Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions